| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -2,542 | -768 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 5,690 | 9,273 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -141,182 | -103,473 |
| Cash and cash equivalents at beginning of period | 228,804 | - |
| Cash and cash equivalents at end of period | 87,622 | - |
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)